Brougham Nicholas D L, Dennett Elizabeth R, Tan Swee T
Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
N Z Med J. 2010 Nov 5;123(1325):59-65.
Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the commonest types of non-melanoma skin cancer (NMSC). The incidence of NMSC has been increasing globally with Australia recording a 1.5-fold increase over the last 17 years. Given that Australia and New Zealand share similar latitude, sun exposure levels, population skin types, and other risk factors, it is conceivable that this increase has also occurred in New Zealand. However, the incidence of NMSC in New Zealand is unknown. The cost of treating NMSC in New Zealand is estimated to be more than NZ$50 million annually, based on extrapolated Australian data. In Australia, NMSC is the most costly burden to its healthcare system, and therefore the Australian Government has allocated resources to improve epidemiological research, and preventative efforts. Currently within New Zealand there is a lack of focus on the NMSC problem. The absence of New Zealand data on the incidence of NMSC has hampered the development of consistent healthcare policies (including preventative measures), that achieve an integrated and sustainable service delivery. A critical analysis of this problem based on longitudinal data is now vitally important to address this neglected problem.
基底细胞癌（BCC）和鳞状细胞癌（SCC）是最常见的非黑素瘤皮肤癌（NMSC）类型。全球范围内，非黑素瘤皮肤癌的发病率一直在上升，澳大利亚在过去17年中增长了1.5倍。鉴于澳大利亚和新西兰在纬度、日照水平、人群皮肤类型及其他风险因素方面相似，可以推测新西兰也出现了这种增长。然而，新西兰非黑素瘤皮肤癌的发病率尚不清楚。根据澳大利亚的数据推断，新西兰每年治疗非黑素瘤皮肤癌的费用估计超过5000万新西兰元。在澳大利亚，非黑素瘤皮肤癌是其医疗系统最沉重的负担，因此澳大利亚政府已拨出资源以改善流行病学研究和预防工作。目前新西兰对非黑素瘤皮肤癌问题缺乏关注。新西兰缺乏非黑素瘤皮肤癌发病率的数据，这阻碍了制定一致的医疗政策（包括预防措施），而这些政策能实现综合且可持续的服务提供。基于纵向数据对这一问题进行批判性分析，对于解决这一被忽视的问题至关重要。
